When compared to other cancers, although the PI3K-AKT pathway presents a relatively low overall mutation rate in ccRCC, the overall activation (phosphorylation levels) of AKT and downstream substrates is high [24–26]. This evidence concerns the gene PIK3CB and nonpapillary renal cell carcinoma.